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Abstract 
Dietary nitrate supplementation has been shown to increase nitric oxide (NO) metabolites, 
reduce blood pressure (BP) and enhance exercise performance. Acute exposure to ultraviolet 
(UV)-A light also increases NO bioavailability and reduces BP. We conducted a randomized, 
counterbalanced placebo-controlled trial to determine the effects of UV-A light alone and in 
combination with nitrate on the responses to sub-maximal steady-state exercise and time trial 
(TT) performance. Nine cyclists (VO2max 53.1 ± 4.4 ml/kg/min) completed five performance 
trials comprising 10 min submaximal steady-state cycling followed by a 16.1 km TT. 
Following a familiarization the final four trials were preceded, in random order, by either 1) 
Nitrate gels (NIT) + UV-A, 2) Placebo (PLA) + UV-A, 3) NIT + Sham light (SHAM) and 4) 
PLA + SHAM (control). The NIT gels (2 x 60 ml gels, ~500 mg nitrate) or a nitrate-depleted 
PLA were ingested 2.5 h prior to the trial. The light exposure consisted of 20J/cm2 whole 
body irradiation with either UV-A or SHAM light. Plasma nitrite was measured pre- and post-
irradiation and VO2 was measured continuously during steady-state exercise. Plasma nitrite 
increased following NIT + SHAM (332 (292 – 377) nM; P=0.029) and NIT + UV-A (456 
(312 – 666) nM; P=0.014) compared to PLA + SHAM (215 (167 – 277) nM). Differences 
between PLA + SHAM and PLA + UV-A (282 (248 – 356) nM) were small and non-
significant. During steady state exercise VO2 was reduced following NIT + UVA (P=0.034) 
and tended to be lower in NIT + SHAM (P=0.086) but not PLA + UV-A (P=0.381) compared 
to PLA + SHAM.TT performance was significantly faster following NIT + UV-A, (1447 ± 41 
s; P=0.005; d=0.47) but not PLA + UV-A (1450 ± 40 s; d=0.41) or NIT + SHAM (1455 ± 47 
s; d=0.28) compared to PLA + SHAM. These findings demonstrate that exposure to UV-A 
light alone does not alter the physiological responses to exercise or improve performance a 
laboratory setting. A combination of UV-A and NIT, however, does improve cycling TT 
performance in this environment which may be due to a larger increase in NO availability. 
1. Introduction  
Since Larsen and colleagues (2007) first reported a reduced oxygen cost of exercise 
following ingestion of sodium nitrate, a growing number of studies have demonstrated the 
ergogenic effects of dietary nitrate supplementation on athletic performers (Lansley et al., 
2011, Cermak et al., 2012, Wylie et al., 2013b, Muggeridge et al., 2014). Research has shown 
that ingestion of nitrate-rich food such as beetroot and spinach can increase circulating levels 
of Nitric Oxide (NO) metabolites via an NO Synthase (NOS) independent pathway (Webb et 
al., 2008). Following absorption of nitrate from the stomach into the plasma, nitrate is 
transported into the saliva via the salivary glands. Bacteria then reduce the nitrate to nitrite 
(Duncan et al., 1995) where, following ingestion, nitrite is potentially reduced to NO when 
exposed to hypoxic (Castello et al., 2006) or acidic environments (Modin et al., 2001).  
 
This increase in NO related products, potentially leading to an increase in NO production, has 
been typically shown to reduce oxygen consumption (VO2) during sub-maximal steady-state 
exercise (Larsen et al., 2007, Bailey et al., 2009) and improve both exercise capacity and 
performance (Bailey et al., 2009, Lansley et al., 2011, Cermak et al., 2012, Muggeridge et al., 
2014). Conversely, several other studies report exercise performance of varying modalities to 
be unaltered by dietary nitrate supplementation (Peacock et al., 2012, Wilkerson et al., 2012, 
Muggeridge et al., 2013). While there are various methodological differences between studies 
that may account for this disparity, it has become apparent that ergogenic effects appear 
minimal in highly-trained endurance cohorts (Peacock et al., 2012, Christensen et al., 2013). 
This may be partly explained by the higher baseline nitrate/nitrite pool in endurance trained 
athletes compared to untrained matched controls (Schena et al., 2002). Evidence from murine 
models also suggests that increases in muscle blood flow and contractile force production 
following nitrate supplementation only occur in Type II muscle fibers (Ferguson et al., 2013, 
Hernandez et al., 2012). One may, therefore, reasonably assume that elite endurance athletes, 
who are known to have high proportions of type I muscle fibers, would be less likely to 
benefit from nitrate supplementation (Andersen et al., 2000). Alternatively, a single low dose 
of dietary nitrate (~4 - 5 mmol) may explain the resultant diminished ergogenic effect of 
dietary nitrate during some endurance based exercise protocols  (Wilkerson et al., 2012, 
Muggeridge et al., 2013, Wylie et al., 2013a).  
 
Intriguingly,  exposing the skin to the Ultra Violet (UV)-A component of sunlight increases 
circulating plasma nitrite via decomposition of photo reactive nitrogen oxides stored in 
dermal cells (Mowbray et al., 2009, Oplander et al., 2009). Opländer and colleagues 
(Oplander et al., 2009) observed that systemic blood pressure (BP) was reduced by 11% 30 
min after UV-A exposure, a finding similar to that of dietary nitrate (Kapil et al., 2010). More 
recently, Liu and colleagues (2014) provided some mechanistic basis for these findings by 
demonstrating UV-A induced NO production also increases forearm blood flow. Therefore, 
given that exposure to UV-A light increases NO bioavailability sufficiently to induce 
measureable physiological effects; it is plausible that it may also enhance exercise 
performance. Furthermore, it remains to be determined whether combining UV-A exposure 
with concomitant nitrate supplementation may potentiate a synergistic effect on NO 
bioavailability given that both offer different routes for increasing plasma NO related 
products.  
 
Despite this, the effects of UV-A exposure, either alone or in combination with nitrate 
supplementation, on plasma nitrite and parameters of exercise performance are currently 
unknown. This is of interest given the reported benefits to exercise performance associated 
with an increased availability of NO related products (Bailey et al., 2009, Lansley et al., 
2011, Cermak et al., 2012, Muggeridge et al., 2014). Therefore, the aim of this study was to 
determine the effects of acute UV-A light exposure with and without simultaneous nitrate 
supplementation on plasma nitrite, the physiological responses to steady-state exercise and 
cycling time trial (TT) performance. We hypothesized that: 1) UV-A exposure would increase 
plasma nitrite and improve exercise performance and 2) UV-A exposure combined with 
nitrate would coalesce to increase plasma nitrite and improve exercise performance to a 
greater extent than either intervention alone. 
 
2. Methods 
2.1 Participants 
Nine male trained-cyclists and triathletes (age 36 ± 6 years, stature 182 ± 5 cm, body mass 
78.9 ± 6.0 kg, and VO2max 53.1 ± 4.4 mL·kg
-1·min-1) volunteered and provided written 
informed consent to participate in the study that was approved by the School of Science 
Ethics Committee at The University of the West of Scotland. All participants were amateur 
competitive athletes who typically completed a minimum of two cycling training sessions per 
week and regularly competed in TT competitions. All procedures were conducted in 
accordance with the Declaration of Helsinki.  
 
2.2 Experimental Design 
Each participant attended the human performance laboratory at the University of the West of 
Scotland on six separate occasions between July and August 2013. The laboratory is located 
in the Hamilton campus at latitude 55.78 degrees north. During the first visit participants 
completed a maximal incremental test to exhaustion in order to determine VO2max and 
maximum work rate (WRmax). This was followed by a familiarization trial and then four 
performance trials conducted at the same time of day (± 1 h), at least five days apart. The 
familiarization trial followed a similar protocol to the performance trials but was not 
preceded by any intervention. Each of the four performance trials were preceded by ingestion 
of either nitrate gels (NIT) or a nitrate-depleted placebo (PLA). The NIT comprised 2 x 60 ml 
concentrated peach-flavored nitrate-rich gels with extracts of Swiss chard and Rhubarb (~8.1 
mmol nitrate, Science in Sport Go+ Nitrates, Lancashire, UK). This dose of dietary nitrate, 
equivalent to ~0.1 mmol nitrate kg-1 body mass, is similar to previous studies that have 
achieved a significant increase in circulating plasma nitrate and nitrite (e.g (Wylie et al., 
2013a, Muggeridge et al., 2014, Lansley et al., 2011, Larsen et al., 2007)). Furthermore, data 
from a recent dose response study suggests that 8.4 mmol is the optimal dose (compared to 
4.2 and 16.8 mmol) to induce beneficial physiological and performance responses (Wylie et 
al., 2013a). The PLA comprised of a peach-flavored gel that were similar in taste and texture 
to NIT but with the nitrate source not added by the manufacturer. The NIT and PLA were 
delivered in identical packaging to ensure that neither participants nor lead investigators were 
able to identify them. Despite a small discrepancy in taste none of the participants had 
consumed a gel prior to testing and were therefore were unable to detect which supplement 
they had consumed. Supplements were ingested 2.5 h prior to arrival at the lab as plasma 
nitrite peaks 2.5 ‒ 3 h after ingestion of an acute dose of nitrate-rich beetroot juice (BR) 
(Webb et al., 2008).  
 
Prior to the performance trials, participants were also exposed on one side of the body 
(equating to the skin surface area exposed when wearing a short-sleeved shirt and shorts) to 
either UV-A light or sham light (SHAM) for a total of 22 min. A Waldmann GH-8 ST unit 
(Herbert Waldmann, GmbH, Villingen-Schwenningen, Germany) containing eight, F851 
100W UV-A bulbs (320-410nm; maximum 351 nm), was positioned 20 cm from the body. At 
this distance a dose of 20 J/cm2 was produced which is the equivalent to two standard 
epithelial doses or 30 min exposure to sunlight at noon on a sunny day in Southern Europe 
(Liu et al., 2014). This dose of UV-A light has been shown to significantly increase plasma 
nitrite immediately after irradiation with values remaining elevated at least 40 min after 
exposure (Liu et al., 2014). During SHAM trials an aluminum foil space blanket covered 
participants, blocking UV-A radiation reaching the skin whilst allowing surface and body 
temperature to rise (Liu et al., 2014). Participants were aware of the significance of the 
aluminum space blanket prior to the start of the study. During the light exposures, participants 
wore only cycling shorts and a visor to protect the face and eyes.  
 
The ingestion of NIT or PLA and exposure to UV-A or SHAM light was administered in a 
randomized counterbalanced design so that each of the four possible combinations of 
interventions was administered: 1) PLA + SHAM (control), 2) PLA + UV-A, 3) NIT + 
SHAM, 4) NIT + UV-A. One of the researchers’, who was not involved in the data collection 
or analysis, randomized the orders of supplementation and light exposure using a Latin-
square model. Prior to each trial participants were asked to abstain from the use of anti-
bacterial mouthwash and consumption of high nitrate food for 48h, not to exercise or 
consume alcohol for 24 h, not to consume caffeine for 6 h or to consume anything other than 
water for 3 h prior to testing.  
 
2.3 Experimental Procedures 
2.3.1 Maximal Exercise Test 
Following standard anthropometric measurements, VO2max and WRmax were measured using a 
continuous graded exercise test on an electronically braked cycle ergometer (Lode Excalibur, 
Groningen, The Netherlands). Participants performed an initial warm-up that consisted of 
cycling at 50 W for 5 min followed by 5 min of static stretching. The exercise test 
commenced at an initial work rate of 50 W and increased by 30 W per min in a linear fashion 
until volitional exhaustion. Throughout the test heart rate (HR) was continuously measured 
via telemetry (Polar Electro, Oy, Finland) and respiratory variables were measured breath by 
breath via indirect calorimetry (Medgraphics Ultima, MGC Diagnostics, MN, USA). The 
indirect calorimeter was calibrated immediately prior to each test using a 3L syringe and both 
calibration and reference gases (calibration gas: 12% O2, 5% CO2; reference Gas: 21% O2, 
0% CO2). Following data collection, VO2 data was filtered to delete values that were less 
than or greater than the rolling seven breath mean ± two standard deviations. All nine 
participants obtained a plateau in VO2 (as determined by a rise in VO2 of <50% of the 
expected increase for the given WR) fulfilling the criteria for VO2max.  Smoothed data was 
subsequently averaged over a rolling seven breath mean and the largest value obtained was 
determined as the participant’s VO2max. Pilot data from our laboratory have shown high 
reproducibility in measurement for these procedures. The coefficient of variation for VO2max 
and WRmax were 1.9 and 0.5 % respectively with an inter-class correlation coefficient for 
single measures of 0.988 (VO2max) and 0.999 (WRmax). 
 
2.3.2 Performance Trials 
Upon arrival at the laboratory, participants were instructed to lie supine for 10 min after 
which BP was determined by standard auscultation using a stethoscope and 
sphygmomanometer (Accoson, London, UK) and 4 ml of venous blood was collected from 
the cephalic vein. Participants were then exposed to 22 min of either UV-A or SHAM light, 
before the measurement of BP was repeated and another venous blood sample collected. 
Blood samples were collected in tubes containing EDTA and immediately centrifuged at 4000 
rpm at 4oC for 10 min. The plasma was then separated into two cryovials and immediately 
frozen and stored at -80oC  
 After completion of the pre-exercise protocol, participants were seated on the cycle ergometer 
(Lode Excalibur, Groningen, The Netherlands) where resting respiratory measurements and 
HR were recorded. Subsequent to this participants cycled at 50 W for 5 min followed 
immediately by 10 min continuous steady-state cycling at 60% of WRmax. Respiratory 
variables and HR were monitored throughout the steady-state exercise period. VO2 data was 
smoothed as previously described and the average value of the last 5 min of exercise was 
used for analysis. 
 
Following the steady-state exercise protocol participants received a 5 min passive rest period 
where they were permitted to ingest water ad libitum and stretch. Following this, they each 
completed a 16.1 km TT on a cycle ergometer (Wattbike, Nottingham, UK) during which 
they were instructed to cycle at a freely chosen velocity and encouraged to complete the 16.1 
km in the shortest time possible. Participants received verbal feedback on the distance they 
had completed at 1 km intervals and every 100 m for the last km. 
 
2.3.3 Plasma Analysis 
Plasma samples were stored for a maximum of 4 months at -80oC for later analysis of nitrite 
via ozone-based chemiluminescence (Rogers et al., 2005). We have described the procedures 
for the determination of nitrite previously (Muggeridge et al., 2013). Briefly, Triiodide 
reagent was heated in a water bath to 50°C and nitrogen gas bubbled through. The purge 
vessel was linked to a trap containing a sodium hydroxide solution that was further connected 
to an NO analyser (Sievers NOA 280i, Analytix, UK). After obtaining a standard curve, blood 
plasma samples were thawed in a water bath at 37°C for 3 min and injected into the purge 
vessel. Nitrite levels were determined by the area under the curve, calculated using Origin 
software (version 7), divided by the gradient of the slope obtained from the standard curve. 
 
2.4 Pharmacokinetic response to SiS GO+nitrates 
The majority of previous studies on dietary nitrate supplementation have utilized BR as the 
nitrate source. The pharmacokinetics of plasma nitrate and nitrite following ingestion of BR 
are already well-established (Webb et al., 2008), but it is unclear whether the response to the 
NIT used in this study is the same. Therefore, in a study run concurrently to the principal 
investigation but with different participants, the pharmacokinetic response to NIT was 
determined. Seven healthy male volunteers participated (age 34 ± 8 years, stature 179 ± 8 cm, 
body mass 81.4 ± 9.9 kg) who were not on any medication, maintained a healthy lifestyle but 
were not competitive athletes. Following a 12 h fast participants reported to the laboratory 
where a venous blood sample was collected and treated as previously described. Participants 
then ingested NIT (two 60 ml gels, 8.1 mmol nitrate, Science in Sport Go+ Nitrates, 
Lancashire, UK) and blood samples were collected 30, 60, 90, 180, 360, 600 and 1440 min 
after ingestion. Plasma nitrite concentration was determined as described in section 2.3.3 and 
plasma nitrate was measured using the reductant vanadium chloride in hydrochloric acid at 
80°C. Participants refrained from eating until >90min post NIT administration after which 
they were allowed a light breakfast. Following 360 min participants received a sandwich 
lunch, and following 600 min were allowed a meal. They then fasted until 1440min but were 
allowed nitrate-free water ad-libitum. 
 
2.5 Data Analysis 
The estimated sample size for the study (n=9) was based on the expected difference in the 
primary outcome measurement (16.1 km TT performance) using data previously collected in 
our laboratory with an α set at 0.05 and β at 0.8. The distributions of the data collected were 
assessed using Shapiro-Wilk tests and when normality was violated, the variable was logged 
transformed (log10) prior to statistical analysis. Data are reported as mean ± SD or the 
geometric mean and mean confidence interval (CI) for log transformed data.  
 
Differences in plasma nitrite and BP between conditions PLA + SHAM; PLA + UV-A; NIT + 
SHAM; NIT + UV-A) were assessed using two-factor repeated measures ANOVA where the 
main effects were ‘condition’ and ‘time’ (pre- vs. post-light exposure) and the condition*time 
interaction was also tested. Analysis of all other physiological variables and TT completion 
time was conducted using one-factor repeated measures ANOVA to establish differences 
between conditions. Post-hoc analysis of significant within-subject effects was performed 
with adjustments for multiple comparisons using the Bonferroni correction. The null 
hypothesis was rejected when P<0.05. Effect size (Cohens d) was calculated and interpreted 
as: small effect > 0.2; medium effect > 0.5; large effect > 0.8. The 95% CI for mean 
differences are included together with P values, where appropriate. All statistical procedures 
were completed using SPSS for Windows version 20. 
 
3. Results 
3.1 Plasma Nitrite responses during intervention study 
Plasma nitrite data from the intervention study is presented in Figure 1. There was a 
significant main effect of ‘condition’ (P=0.001) on plasma nitrite concentration. There was 
no significant main effect for time (P=0.944) or the condition*time interaction (P=0.083). 
Prior to the light-exposure, plasma nitrite in the NIT + SHAM (399 (345 – 461) nM) 
condition was higher than in the control (247 (179 – 343) nM, P=0.024, 95% CI 17 – 257 
nM). Plasma nitrite in the NIT + UV-A (391 (291 – 526) nM) condition tended to be higher 
than in the control (P=0.068,95% CI -20 – 320 nM). There was no difference in plasma 
nitrite pre-light exposure between the control and PLA + UV-A conditions (265 (203 – 347) 
nM, P=1.000). 
 
There was a significant decline in plasma nitrite from pre- to post-light exposure in the 
control condition (P=0.036, 95% CI 4 – 82 nM) and a tendency for a decline in the NIT + 
SHAM condition (P=0.060, 95% CI 4 – 143 nM). There was no change in plasma nitrite 
from pre- to post-light exposure in both UV-A conditions (PLA + UV-A, P=0.645; NIT + UV-
A, P=0.208). In the post-light exposure measurements, plasma nitrite was higher in both NIT 
+ SHAM (332 (292 – 377) nM; P=0.029, 95% CI 25 – 197 nM) and NIT + UVA (456 (312 – 
666) nM; P=0.014, 95% CI -32 – 599 nM) conditions compared to the control (215 (167 – 
277) nM).There were no differences in post-light exposure measurements of plasma nitrite 
between the control and PLA + UV-A conditions (282 (248 – 356) nM, P=0.781) or any other 
comparisons between interventions (all P>0.20). Magnitude based inferences suggest that all 
interventions resulted in a large increase in plasma nitrite concentration compared to the 
control (PLA + UV-A, d=0.85; NIT + SHAM, d=1.64; NIT + UV-A, d=1.80). 
 
 
 Figure 1: Geometric mean and 95% CI (error bars) of plasma nitrite concentration in the 
control (PLA + SHAM) and experimental (PLA + UV-A; NIT + SHAM; NIT + UV-A) 
conditions for pre- (grey bars) and post-light (white bars) exposure. a denotes a significant 
decline in plasma nitrite from pre- to post-light exposure (P=0.036).  b denotes a significant 
higher plasma nitrite compared to PLA + SHAM pre-light exposure (P=0.024). c denotes a 
significant higher plasma nitrite compared to PLA + SHAM post-light exposure (NIT + 
SHAM, P=0.029; NIT + UV-A P=0.014). 
 
3.2 Blood Pressure 
The data for systolic, diastolic and mean arterial BP are presented in Table 1. 
 
3.2.1 Systolic Blood Pressure 
There was a significant main effect of both ‘condition’ (P=0.002) and ‘time (P<0.001) on 
systolic BP and a condition*time interaction (P=0.008). Prior to the light-exposure, systolic 
BP tended to be lower in the NIT + SHAM (P=0.090, 95% CI -1 – 9 mmHg) and NIT + UV-
A (P=0.052, 95% CI 0 – 10 mmHg) conditions compared to the control. Compared to the 
PLA + UV-A trial, pre-light exposure systolic BP was lower in the NIT + SHAM condition 
(P=0.031, 95% CI 0 – 7 mmHg) and tended to be lower in the NIT + UV-A (P=0.061, 95% 
CI 0 – 9 mmHg) condition. There were no differences in systolic BP pre-light exposure 
between the control and PLA + UV-A conditions (P=1.0).  
 
There was a significant decline in systolic BP from pre- to post-light exposure in the control 
condition and all three experimental conditions (all P<0.05). In the post-light exposure 
measurements, systolic BP tended to be lower in the PLA + UV-A condition (P=0.057, 95% 
CI 0 – 10 mmHg) and was significantly lower in the NIT + UV-A condition (P=0.001, 95% 
CI 3 – 10 mmHg) compared to the control. There were no differences in post-light exposure 
measurements of systolic BP between the control and NIT + SHAM conditions (P=0.133) or 
any other comparisons between interventions (all P>0.20).  
 
3.2.2 Diastolic Blood Pressure 
There were no main effects of ‘condition’ (P=0.570) or ‘time’ (P=0.128) on diastolic BP 
although there was a significant condition*time interaction (P=0.042). Diastolic BP declined 
from pre- to post-light exposure in the PLA + UVA trial (P=0.045, 95% CI 1 – 5 mmHg) with 
a trend for a reduction in the NIT + SHAM trial (P=0.084, 95% CI 0 – 5 mmHg). There were 
no differences in diastolic BP from pre- to post-light exposure in the other conditions (both 
P>0.70).  
 
 
 
  
Table 1. Blood pressure variables measured pre-light 
and post-light exposure in the control (PLA + SHAM) 
and experimental conditions. 
Condition and Variable Pre-Light Post-Light 
   
PLA + SHAM   
Systolic 124 ± 8 122 ± 7b 
Diastolic 72 ± 3 71 ± 3 
MAP 89 ± 4 88 ± 4 
   
PLA + UVA   
Systolic 122 ± 7 116 ± 5b 
Diastolic 72 ± 6 70 ± 7b 
MAP 89 ± 5 85 ± 6b 
   
NIT + SHAM   
Systolic 119 ± 7a 116 ± 8b 
Diastolic 70 ± 6 70 ± 6 
MAP 86 ± 6 85 ± 6 
   
NIT + UVA   
Systolic 118 ± 8 115 ± 6b,c 
Diastolic 71 ± 4 69 ± 5 
MAP 87 ± 4 84 ± 4b,c 
Data are presented as mean ± SD. 
a denotes a difference from PLA + UVA pre-light 
measurement (P<0.05) 
b denotes a difference from pre-light measurement in 
the same condition (P<0.05)  
c denotes a difference from PLA + SHAM post-light 
measurement (P<0.05)  
 
 
3.2.3 Mean Arterial Blood Pressure 
There was no main effect of ‘condition’ (P=0.114) on mean arterial BP although there was a 
significant main effect of ‘time’ (P=0.012) and a condition*time interaction (P=0.010). Prior 
to the light-exposure, there were no differences in mean arterial BP between conditions (all 
P>0.10). There was a significant reduction in mean arterial BP from pre- to post-light 
exposure in PLA + UVA (P=0.002, 95% CI 2 – 6 mmHg) and NIT + UVA conditions 
(P=0.025, 95% CI 0 – 5 mmHg) but no differences in the other trials (both P>0.20). In the 
post-light exposure measurements, mean arterial BP was significantly lower in the NIT + UV-
A trial compared to the control (P=0.030, 95% CI 0 – 7 mmHg). There were no differences 
between other conditions (all P>0.50). 
 
3.3 Cardio-respiratory Variables 
The data for VO2 and HR at rest and during steady-state exercise are presented in Table 2. 
 
There were no differences in HR (P=0.822) or VO2 (P=0.385) between conditions at rest. 
During steady-state exercise, VO2 was lower in NIT + UV-A (P=0.034, 95% CI 7 – 136 
ml/min, d=0.38) and tended to be lower in NIT + SHAM (P=0.086, 95% CI -10 – 115 
ml/min, d=0.30) compared to the control condition. There was no difference in steady-state 
exercise VO2 between the control and PLA + UV-A trials (P=0.381). There were no 
differences in HR during exercise between conditions (all P>0.30). 
 
Table 2. Oxygen consumption and heart rate at rest and during steady-state exercise in the 
control (PLA + SHAM) and experimental conditions 
  PLA + SHAM PLA + UV-A NIT + SHAM NIT + UV-A 
Rest 
    
VO2 (ml/min) 305 ± 58 288 ± 58 321 ± 78 310 ± 61 
HR (bpm) 61 ± 12 59 ± 13 61 ± 8 58 ± 10 
     
Exercise 
    
VO2 (ml/min) 2972 ± 171 2924 ± 181 2919 ± 179 2900 ± 209
a 
HR (bpm) 146 ± 14 148 ± 14 148 ± 10 146 ± 11 
     Data are presented as mean ± SD. 
a denotes a difference from PLA + SHAM  measurement (P<0.05) 
 
 3.4 Time Trial Performance 
There were no differences in time to complete the TT between control and familiarization 
trials (control: 1469 ± 52 s; familiarization: 1467 ± 61 s; P=0.846). Performance in the TT 
was significantly faster following NIT + UV-A, (1447 ± 41 s; P=0.005; 95% CI 9 – 35 s; 
d=0.47) but not PLA + UV-A (1450 ± 40 s; P=0.122; d=0.41) or NIT + SHAM (1455 ± 47 s; 
P=0.106; d=0.28) compared to the control. However, magnitude based inferences suggest 
that all experimental interventions result in a small benefit to TT performance. Post-hoc 
analysis of the data determined a power of 0.608 for TT performance in the present study. 
 
3.5 Pharmacokinetic Response 
Plasma nitrite and nitrate data from the pharmacokinetic experiment are presented in Figure 
2. Plasma nitrite peaked 90 min after ingestion of NIT and remained elevated above baseline 
until 6 h post-ingestion. Plasma nitrate peaked, on average, 1 h post-ingestion and remained 
elevated above baseline even at 24hrs post-ingestion. The half-lives for plasma nitrate and 
nitrite were 6 h and 5 h, respectively. 
 
 
 
 
 
 
 
 
 
 Figure 2: Change from baseline in group mean ± SD plasma nitrite (top panel) and nitrate 
(bottom panel) concentration after ingestion of 2 x 60 g SiS GO+nitrates gels (~500 mg 
nitrate). 
 
4. Discussion 
Exogenous supplementation with dietary nitrate increases the bioavailability of NO which 
has been shown in some conditions to reduce the oxygen cost of exercise and improve 
performance (Lansley et al., 2011, Cermak et al., 2012, Wylie et al., 2013b, Muggeridge et 
al., 2014). The present study explored the physiological and ergogenic effects of short-term 
exposure to UV-A light as a novel method to increase circulating NO metabolites both with 
and without ingestion of NIT. The principal finding was that exposure to UV-A light alone 
was not sufficient to significantly improve cycling TT performance although magnitude 
based inferences suggest a small positive effect. However, combining UV-A exposure with 
the ingestion of NIT reduced systolic and mean arterial BP at rest and VO2 during steady-
state exercise and significantly improved 16.1 km TT performance. As a result, these findings 
suggest that the extent of the rise in plasma nitrite influences the extent of the physiological 
and ergogenic effects. Data from the present study suggests that combining short-duration 
UV-A exposure with acute supplementation of NIT may be an efficacious method to increase 
the availability of NO. It is important to highlight that the dose of UV-A in the present study 
was small, did not cause burning and was administered on only two occasions.  However, 
regular exposure to acute bouts of UV-A or larger doses would not be recommended at 
present given the possible increased risk of skin cancer, particularly for individuals with pale 
skin (Rigel, 2008).  
4.1 Effects of UV-A Light on Plasma Nitrite and Blood Pressure 
In contrast to our hypothesis and previous research (Mowbray et al., 2009, Oplander et al., 
2009, Liu et al., 2014), exposure to UV-A light resulted in only a small, non-significant 
increase in plasma nitrite concentration compared to baseline. However, plasma nitrite 
declined from pre- to post-light exposure in the two SHAM trials (by 43 nM in PLA + SHAM 
and 69 nM in NIT + SHAM), a finding also reported by Liu and colleagues (2014). Thus 
while exposure to UV-A light did not increase plasma nitrite per se, it did attenuate the 
consequential decline of lying supine for ~30 min. Indeed, systolic BP following exposure to 
UV-A also tended to be lower than in the control trial suggesting that this small absolute 
increase in plasma nitrite was substantial enough to induce physiological effects. While we 
can only speculate as to mechanisms underpinning the reduction in nitrite during SHAM 
trials, it is well established that circumferential wall tension and arterial strain are reduced in 
the supine position compared to standing (Gemignani et al., 2008). A reduction in arterial 
shear stress is also associated with reduced NO production by the endothelial cells (Davies, 
1995). Circulating nitrite is a combination of oxidized NOS-derived NO, of which the eNOS 
component falls with reduced shear stress at rest, and exogenous nitrate derived from an 
individual’s diet. We propose that this fall in eNOS derived NO offsets the rise from chemical 
reduction of the oral NIT. Furthermore, movement from a standing to a supine posture causes 
plasma volume to expand as fluid moves from the cells to the blood (Hagan et al., 1978). 
These fluid shifts may cause a dilution in some plasma metabolite concentrations.  
 
Exposure to UV-A light has been consistently reported to increase plasma nitrite (Mowbray et 
al., 2009, Oplander et al., 2009, Liu et al., 2014) which in the present study appears to have 
offset these postural effects. The skin is known to contain large stores of various NO 
metabolites (principally nitrate) (Mowbray et al., 2009) which appear to be liberated in 
response to UV-A irradiation (Liu et al., 2014). In the present study, the individual response 
to the UV-A dose was variable. Some individuals responded to the UV-A exposure with large 
increases in plasma nitrite whereas others experienced a reduction mirroring the SHAM trials 
(data not shown). With only a small sample size to draw upon it is difficult to offer any firm 
explanation for the current data although skin type, previous exposure to UV-A, skin surface 
area and training status are all factors that could have conceivably influenced the response. 
Nevertheless, inter-individual variability is a well-established facet of the dietary nitrate 
supplementation literature that is deserving of further attention. Moreover, the dose-response 
pharmacokinetics of UV-A exposure and NO metabolism are currently unknown, and 
therefore it is unclear whether a longer exposure to the UV-A light source would have 
increased plasma nitrite concentration beyond what we have reported.  
 
Given previous findings it seems likely that the reduction in systolic BP following exposure 
to UV-A was mediated via a NO mechanism that is independent of temperature (Liu et al., 
2014). However, the photolytic process involved in the formation of NO may also contribute 
to these effects. Whilst UV-A can produce NO directly from cutaneous nitrite stores 
(Rodriguez et al., 2003, Oplander et al., 2010, Suschek et al., 2010) NO production from 
nitrate photolysis is reported to be low, however thiols are known to enhance this process 
(Dejam et al., 2003). Therefore, some have suggested that the thiol side chain in the amino 
acid cysteine (which is present in the epidermis) may augment NO production from 
cutaneous nitrate stores. Therefore our interpretation of NO bioavailability in the present 
study is limited as circulating nitrite was the sole marker of changes to the NO pool. 
Additional measurements of systemic NO bioavailability (including nitrate and S-
Nitrosothiols (RSNO)) and cutaneous stores are worthy of further investigation. 
 
4.2 Effects of Nitrate Ingestion on Plasma NO related products and Blood Pressure 
In the present study, the ingestion of NIT increased plasma nitrite (by 137 nM in NIT + 
SHAM, 150 nM in NIT + UV-A and 179 nM in the pharmacokinetics experiment) and tended 
to reduce systolic BP, which is consistent with the majority of other studies (e.g Webb et al., 
2008, Kapil et al., 2010). However, it was surprising to note from the pharmacokinetic study 
that the peak occurrence of plasma nitrite following ingestion of NIT differs from BR. Plasma 
nitrite has been reported to peak 2.5 ‒ 3 h after ingestion of a single dose of BR whereas the 
response appears to be substantially quicker following NIT. Whether these differences are 
due to the source of nitrate in NIT (rhubarb and Swiss chard), the viscosity and volume of the 
supplements or simply differences in sample populations is not clear at present and would 
only be revealed by comparing nitrate supplements directly in the same cohort. Accordingly, 
although plasma nitrite was still unquestionably higher 2.5 h after ingestion, one may argue 
that this unanticipated alteration in the pharmacokinetic response to NIT meant that the 
timing of the dose was not optimal. Additionally, as with the response to UV-A, the 
individual changes in circulating nitrite following NIT were variable.  
 
4.3 Evidence for a Cumulative Response to UV-A Light and Nitrate Ingestion 
Our data show for the first time, that the known effects of dietary nitrate on plasma nitrite and 
BP can be enhanced when taken in combination with an acute exposure to UV-A light. The 
increase in plasma nitrite was largest following NIT + UV-A (Fig. 1) and this intervention 
was the only combination in the present study to significantly reduce mean arterial BP. Given 
that consumption of dietary nitrate and irradiation with UV-A light are both known to 
separately increase NO availability through different mechanisms, these effects are perhaps 
not unsurprising. Where ingestion of dietary nitrate is known to increase plasma NO via a 
NOS independent pathway involving the reduction of dietary nitrate to nitrite in the gut and 
oral cavity, UV-A light releases NO from pre-formed stores in the skin (Liu et al., 2014). 
Indeed, Liu and colleagues (2014) suggest that the response to UV-A irradiation is not 
dependent on systemic nitrate availability or NOS activity. Irrespective, the apparent 
symbiotic effects of diet (nitrate) and environment (UV-A from sunlight) on BP offers an 
intriguing new avenue for future research. 
 
4.4 Effects of NIT and UV-A on Steady-State Exercise and Time Trial Performance  
The cumulative effects of dietary nitrate and UV-A are also apparent in the physiological 
responses to steady-state exercise and TT performance. Although VO2 tended to be lower 
following NIT + SHAM compared to the control trial, this parameter was significantly 
reduced following NIT + UV-A. Furthermore, NIT + UV-A was the only intervention that 
resulted in a statistically significant improvement in TT performance compared to the control. 
The precise mechanisms responsible for the reduced VO2 during exercise are unquestionably 
related to an increase in NO related products but remain a matter of some controversy. In 
short, there are data suggesting that an increased bioavailability of NO improves the 
efficiency of mitochondrial respiration (Larsen et al., 2011) and reduces the energy cost of 
muscle force production (Bailey et al., 2010). The various purported mechanisms underlying 
these effects are the subject of a recent review article by Jones (2014) which neatly 
summarizes the extent of our knowledge on this topic.  
 
While the present study does not advance our mechanistic understanding of dietary nitrate 
supplementation during exercise, it does support the notion that the response is dependent on 
the extent of the rise in plasma nitrite following the intervention. Where NIT + UV-A induced 
the largest increase in plasma nitrite, it also resulted in the largest reduction in VO2 during 
steady-state exercise and improvement in TT performance. Wylie et al. (2013a) reported 
similar findings in their investigation into the dose-response to BR. In this study 8.4 mmol of 
BR increased plasma nitrite to a greater extent than 4.2 mmol which also coincided with a 
greater reduction in the oxygen cost of steady-state exercise and improvement in 
performance. The smaller increase in plasma nitrite following a smaller dose of dietary nitrate 
or the apparent blunted response in trained athletes compared to recreationally active 
individuals has been suggested by some authors to be the reason why dietary nitrate 
supplementation does not improve performance on all occasions (Peacock et al., 2012, 
Wilkerson et al., 2012, Muggeridge et al., 2013). Nevertheless, we did not observe a 
correlation between the changes in plasma nitrite and improvement in TT performance in the 
present study (data not presented).  Additionally there is well-constructed mechanistic data 
suggesting a preferential effect of dietary nitrate on type II muscle fibers. Hernandez et al., 
(2012)   demonstrated that supplementation with beetroot juice increased force production of 
the fast twitch muscle fibers of mice which was also associated with an alteration in muscle 
protein expression. Again using a murine model, Ferguson et al., (2013) also reported that the 
increase in muscle blood flow following supplementation with beetroot juice only occurred in 
type II muscle fibers. It is conceivable, therefore, that the blunted response to nitrate 
supplementation may be attributable to the training status or indeed the muscle fiber type 
distribution of the participants. The aforementioned expectation that elite endurance athletes 
will have a higher proportion of type I fibers (Andersen et al., 2000) certainly offers some 
weight to this argument. In contrast, team sports such as rugby require short, intermittent 
bouts of anaerobic work and trained athletes in these sports are reported to have a higher 
percentage of type II fibers (Jardine et al., 1988). Recent work by Wylie et al .,(2013b) 
supports this notion where performance gains were reported in trained team sports players 
when performing intense intermittent exercise. 
 
Our work also highlights a pertinent methodological issue for researchers investigating the 
effects of dietary nitrate supplementation on markers of health and performance in human 
subjects. The UV-A dose in this study was equivalent to only 30 min exposure to sunlight yet 
resulted in small alterations in the plasma nitrite response to lying supine, reduced BP and 
may cause small improvements in TT performance. Consequently, we suggest that the time of 
year when data are collected should be standardized where possible and the experimental 
location (latitude) should be a factor worthy of consideration in the interpretation and 
comparison of future NO related work. Indeed, this point also reveals a limitation of our own 
work. Although all 54 trials were conducted during a relatively narrow window (July – 
August, 2013), this transpired to be during a period of sustained unusually warm weather in 
Scotland. Exposure to UV-A light outside of the laboratory was not controlled and nor was it 
measured. The effects of UV-A exposure on plasma nitrite and the consequent physiological 
responses are known to be sustained for at least 40 min after exposure (Liu et al., 2014). The 
majority of participants, however, completed their trials in the late afternoon or evening after 
which they had been typically working in an indoor environment for the majority of the day. 
It is unclear at present whether additional basal exposure to sunlight would be substantial 
enough to cause a lasting physiological effect that would have impacted our findings. 
 
5.0 Conclusion 
The principal findings of the present study were that exposure to UV-A light subsequent to 
ingestion of a NIT improved the physiological responses to steady-state exercise and 16.1 km 
cycling TT performance. Furthermore, we provide some evidence of a cumulative effect of 
dietary nitrate and UV-A derived NO, whereby the increase in plasma nitrite was larger than 
with either intervention alone. This study offers the intriguing possibility that a combination 
of naturally occurring environmental and dietary factors may coalesce to enhance cycling 
performance. However, the potential long term risks of chronic exposure to UV-A light are 
unclear at present and further research is required to explore this. Researchers should also 
carefully consider the potential effects of natural sunlight exposure during study design and 
interpretation of their findings given the important role of NO in energy metabolism and 
exercise performance.  
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